Related Experiment Video
Updated: Mar 17, 2026

03:52
The Creation of a Rat Model for Osteosarcopenia via Ovariectomy
Published on: February 21, 2025
1.4K
Does Secondary Renal Osteopathy Exist in Companion Animals?
Gilad Segev1, Hagar Meltzer1, Anna Shipov1
1Koret School of Veterinary Medicine, The Hebrew University of Jerusalem, Hertzel Street, Rehovot 76100, Israel.
Summary
Secondary renal hyperparathyroidism, a complication of chronic kidney disease, inevitably weakens bone quality in pets. This increases fracture risk, particularly in cats due to longer disease duration, requiring clinical attention.
Area of Science:
- Veterinary Medicine
- Nephrology
- Bone Metabolism
Background:
- Secondary renal hyperparathyroidism is a common complication of chronic kidney disease (CKD) in both humans and companion animals.
- CKD-associated mineral and bone disorder (CKD-MBD) leads to significant skeletal abnormalities.
- Bone quality deterioration and increased fracture risk are documented in human CKD patients.
Purpose of the Study:
- To evaluate bone quality in companion animals with chronic kidney disease.
- To compare the impact of CKD on bone quality in cats versus dogs.
- To highlight the clinical implications of impaired bone quality in animals with CKD.
Main Methods:
- This study reviews existing evidence on bone quality in companion animals with CKD.
- Comparative analysis of bone quality data between feline and canine CKD patients.
- Assessment of factors contributing to bone deterioration, such as disease duration.
Main Results:
- Evidence indicates decreased bone quality in companion animals suffering from CKD.
- Bone quality impairment appears more pronounced in cats than in dogs.
- This difference may be attributed to the typically longer course of CKD in cats.
Conclusions:
- Companion animals with CKD exhibit reduced bone quality and elevated fracture risk.
- Cats may be at a higher risk due to a more prolonged disease progression.
- Veterinarians should consider these skeletal risks when managing animals with chronic kidney disease.
More Related Videos
Related Concept Videos
Bone Disorders
6.0K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
6.0K
What is the Skeletal System?
58.6K
Overview
58.6K
Osteoclasts in Bone Remodeling
4.6K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.6K
Chronic Kidney Disease II: Clinical Manifestations
890
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
890

